Skip to main content
Top
Published in: Rheumatology International 3/2011

01-03-2011 | Letter to the Editor

SNP–SNP interactions within APOE gene influence plasma lipids in postmenopausal osteoporosis

Authors: Monica Singh, Puneetpal Singh, Pawan Kumar Juneja, Surinder Singh, Taranpal Kaur

Published in: Rheumatology International | Issue 3/2011

Login to get access

Excerpt

Dear Sirs, …
Literature
1.
go back to reference Yamaguchi T, Sugimoto T, Yano S, Yamauchi M, Sowa H, Chen Q, Chihara K (2002) Plasma lipids and osteoporosis in postmenopausal women. Endocr J 49:211–217CrossRefPubMed Yamaguchi T, Sugimoto T, Yano S, Yamauchi M, Sowa H, Chen Q, Chihara K (2002) Plasma lipids and osteoporosis in postmenopausal women. Endocr J 49:211–217CrossRefPubMed
2.
go back to reference Sivas F, Alemdaroğlu E, Elverici E, Kuluğ T, Ozoran K (2009) Serum lipid profile: its relationship with osteoporotic vertebrae fractures and bone mineral density in Turkish postmenopausal women. Rheumatol Int 29:885–890CrossRefPubMed Sivas F, Alemdaroğlu E, Elverici E, Kuluğ T, Ozoran K (2009) Serum lipid profile: its relationship with osteoporotic vertebrae fractures and bone mineral density in Turkish postmenopausal women. Rheumatol Int 29:885–890CrossRefPubMed
3.
go back to reference Parhami F (2003) Possible role of oxidized lipids in osteoporosis: could hyperlipidemia be a risk factor? Prostaglandins Leukot Essent Fatty Acids 68:373–378CrossRefPubMed Parhami F (2003) Possible role of oxidized lipids in osteoporosis: could hyperlipidemia be a risk factor? Prostaglandins Leukot Essent Fatty Acids 68:373–378CrossRefPubMed
4.
go back to reference Kohlmeier M, Saupe J, Schaefer K, Asmus G (1998) Bone fracture history and prospective bone fracture risk of hemodialysis patients are related to apolipoprotein E genotype. Calcif Tissue Int 62:278–281CrossRefPubMed Kohlmeier M, Saupe J, Schaefer K, Asmus G (1998) Bone fracture history and prospective bone fracture risk of hemodialysis patients are related to apolipoprotein E genotype. Calcif Tissue Int 62:278–281CrossRefPubMed
5.
go back to reference Hak AE, Witteman JC, Hugens W, Keyzer JJ, Pop VJ, Uitterlinden AG, Pols HA (2004) The increase in cholesterol with menopause is associated with the apolipoprotein E genotype. A population-based longitudinal study. Atherosclerosis 175:169–176CrossRefPubMed Hak AE, Witteman JC, Hugens W, Keyzer JJ, Pop VJ, Uitterlinden AG, Pols HA (2004) The increase in cholesterol with menopause is associated with the apolipoprotein E genotype. A population-based longitudinal study. Atherosclerosis 175:169–176CrossRefPubMed
6.
go back to reference Heikkinen AM, Niskanen L, Ryynänen M, Komulainen MH, Tuppurainen MT, Parviainen M, Saarikoski S (1999) Is the response of serum lipids and lipoproteins to postmenopausal hormone replacement therapy modified by ApoE genotype? Arterioscler Thromb Vasc Biol 19:402–407PubMed Heikkinen AM, Niskanen L, Ryynänen M, Komulainen MH, Tuppurainen MT, Parviainen M, Saarikoski S (1999) Is the response of serum lipids and lipoproteins to postmenopausal hormone replacement therapy modified by ApoE genotype? Arterioscler Thromb Vasc Biol 19:402–407PubMed
7.
go back to reference Long JR, Zhao LJ, Liu PY et al (2004) Patterns of linkage disequilibrium and haplotype distribution in disease candidate genes. BMC Genetics 5:11–17CrossRefPubMed Long JR, Zhao LJ, Liu PY et al (2004) Patterns of linkage disequilibrium and haplotype distribution in disease candidate genes. BMC Genetics 5:11–17CrossRefPubMed
8.
go back to reference Ma L, Runesha HB, Dvorkin D, Garbe JR, Da Y (2008) Parallel and serial computing tools for testing single-locus and epistatic SNP effects of quantitative traits in genome-wide association studies. BMC Bioinformatics 9:315CrossRefPubMed Ma L, Runesha HB, Dvorkin D, Garbe JR, Da Y (2008) Parallel and serial computing tools for testing single-locus and epistatic SNP effects of quantitative traits in genome-wide association studies. BMC Bioinformatics 9:315CrossRefPubMed
9.
go back to reference He LN, Recker RR, Deng HW, Dvornyk V (2009) A polymorphism of apolipoprotein E (APOE) gene is associated with age at natural menopause in Caucasian females. Maturitas 62:37–41CrossRefPubMed He LN, Recker RR, Deng HW, Dvornyk V (2009) A polymorphism of apolipoprotein E (APOE) gene is associated with age at natural menopause in Caucasian females. Maturitas 62:37–41CrossRefPubMed
10.
go back to reference Novelli V, Viviani Anselmi C, Roncarati R, Guffanti G, Malovini A, Piluso G, Puca AA (2008) Lack of replication of genetic associations with human longevity. Biogerontology 9:85–92CrossRefPubMed Novelli V, Viviani Anselmi C, Roncarati R, Guffanti G, Malovini A, Piluso G, Puca AA (2008) Lack of replication of genetic associations with human longevity. Biogerontology 9:85–92CrossRefPubMed
11.
go back to reference Martin ER, Lai EH, Gilbert JR et al (2000) SNPing away at complex diseases: analysis of single-nucleotide polymorphisms around APOE in Alzheimer disease. Am J Hum Genet 67:383–394CrossRefPubMed Martin ER, Lai EH, Gilbert JR et al (2000) SNPing away at complex diseases: analysis of single-nucleotide polymorphisms around APOE in Alzheimer disease. Am J Hum Genet 67:383–394CrossRefPubMed
Metadata
Title
SNP–SNP interactions within APOE gene influence plasma lipids in postmenopausal osteoporosis
Authors
Monica Singh
Puneetpal Singh
Pawan Kumar Juneja
Surinder Singh
Taranpal Kaur
Publication date
01-03-2011
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 3/2011
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-010-1449-7

Other articles of this Issue 3/2011

Rheumatology International 3/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.